| 000 | 01778 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516132655.0 | ||
| 264 | 0 | _c20131018 | |
| 008 | 201310s 0 0 eng d | ||
| 022 | _a1432-5195 | ||
| 024 | 7 |
_a10.1007/s00264-013-1781-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrunnekreef, Jaap J | |
| 245 | 0 | 0 |
_aIs etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty? _h[electronic resource] |
| 260 |
_bInternational orthopaedics _cApr 2013 |
||
| 300 |
_a583-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aArthroplasty, Replacement, Hip _xadverse effects |
| 650 | 0 | 4 |
_aCyclooxygenase 2 Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aEtoricoxib |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHip Joint _xdiagnostic imaging |
| 650 | 0 | 4 | _aHip Prosthesis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOssification, Heterotopic _xetiology |
| 650 | 0 | 4 |
_aOsteoarthritis, Hip _xsurgery |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aPyridines _xadministration & dosage |
| 650 | 0 | 4 | _aRadiography |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aSulfones _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHoogervorst, Paul | |
| 700 | 1 | _aPloegmakers, Marieke J | |
| 700 | 1 | _aRijnen, Wim H | |
| 700 | 1 | _aSchreurs, Berend W | |
| 773 | 0 |
_tInternational orthopaedics _gvol. 37 _gno. 4 _gp. 583-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00264-013-1781-0 _zAvailable from publisher's website |
| 999 |
_c22456554 _d22456554 |
||